Date: ClinicalTrials.gov processed this data on October 25, 2016

URL: https://clinicaltrials.gov/show/NCT00000209

Org Study Id: NIDA-06082-5

NCT ID: NCT00000209

Title: Buprenorphine Dosing Interval - 5

Official Title: Buprenorphine Dosing Interval

Summary: 
      The purpose of this study is to explore the feasibility of extending the dosing interval of
      well maintained buprenorphine patients to 48 and 72 hours, leading to eventual 3 times/week
      dosing.
    

Overall Status: Completed

Start Date: November 1992

Phase: Phase 2

Gender: Both

Minimum Age: 21

Maximum Age: 50

Healthy Volunteers: No

